BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22801748)

  • 41. pH-Triggered controlled drug release from mesoporous silica nanoparticles via intracelluar dissolution of ZnO nanolids.
    Muhammad F; Guo M; Qi W; Sun F; Wang A; Guo Y; Zhu G
    J Am Chem Soc; 2011 Jun; 133(23):8778-81. PubMed ID: 21574653
    [TBL] [Abstract][Full Text] [Related]  

  • 42. pH-responsive release of acetal-linked melittin from SBA-15 mesoporous silica.
    Schlossbauer A; Dohmen C; Schaffert D; Wagner E; Bein T
    Angew Chem Int Ed Engl; 2011 Jul; 50(30):6828-30. PubMed ID: 21688354
    [No Abstract]   [Full Text] [Related]  

  • 43. Functionalized mesoporous silica materials for controlled drug delivery.
    Yang P; Gai S; Lin J
    Chem Soc Rev; 2012 May; 41(9):3679-98. PubMed ID: 22441299
    [TBL] [Abstract][Full Text] [Related]  

  • 44. pH- and photo-switched release of guest molecules from mesoporous silica supports.
    Aznar E; Marcos MD; Martínez-Máñez R; Sancenón F; Soto J; Amorós P; Guillem C
    J Am Chem Soc; 2009 May; 131(19):6833-43. PubMed ID: 19402643
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stimuli-free auto-modulated material release from mesoporous nanocompartment films.
    Ji Q; Miyahara M; Hill JP; Acharya S; Vinu A; Yoon SB; Yu JS; Sakamoto K; Ariga K
    J Am Chem Soc; 2008 Feb; 130(8):2376-7. PubMed ID: 18251466
    [No Abstract]   [Full Text] [Related]  

  • 46. Magnetic-sensitive silica nanospheres for controlled drug release.
    Hu SH; Liu TY; Huang HY; Liu DM; Chen SY
    Langmuir; 2008 Jan; 24(1):239-44. PubMed ID: 18052081
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Yoctowell cavities on magnetic silica nanoparticles for pH stimuli-responsive controlled release of drug molecules.
    Bhosale SV
    Chemistry; 2014 Apr; 20(18):5253-7. PubMed ID: 24700743
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mesoporous silica nanoparticle-based double drug delivery system for glucose-responsive controlled release of insulin and cyclic AMP.
    Zhao Y; Trewyn BG; Slowing II; Lin VS
    J Am Chem Soc; 2009 Jun; 131(24):8398-400. PubMed ID: 19476380
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Study on the adsorption mechanism of DNA with mesoporous silica nanoparticles in aqueous solution.
    Li X; Zhang J; Gu H
    Langmuir; 2012 Feb; 28(5):2827-34. PubMed ID: 22182067
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The intracellular controlled release from bioresponsive mesoporous silica with folate as both targeting and capping agent.
    Guo R; Li LL; Zhao WH; Chen YX; Wang XZ; Fang CJ; Feng W; Zhang TL; Ma X; Lu M; Peng SQ; Yan CH
    Nanoscale; 2012 Jun; 4(11):3577-83. PubMed ID: 22543578
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A magnetic, reversible pH-responsive nanogated ensemble based on Fe3O4 nanoparticles-capped mesoporous silica.
    Gan Q; Lu X; Yuan Y; Qian J; Zhou H; Lu X; Shi J; Liu C
    Biomaterials; 2011 Mar; 32(7):1932-42. PubMed ID: 21131045
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanized silica nanoparticles based on reversible bistable [2]pseudorotaxanes as supramolecular nanovalves for multistage pH-controlled release.
    Wang M; Chen T; Ding C; Fu J
    Chem Commun (Camb); 2014 May; 50(39):5068-71. PubMed ID: 24714998
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistance.
    He Q; Gao Y; Zhang L; Zhang Z; Gao F; Ji X; Li Y; Shi J
    Biomaterials; 2011 Oct; 32(30):7711-20. PubMed ID: 21816467
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hindered disulfide bonds to regulate release rate of model drug from mesoporous silica.
    Nadrah P; Maver U; Jemec A; Tišler T; Bele M; Dražić G; Benčina M; Pintar A; Planinšek O; Gaberšček M
    ACS Appl Mater Interfaces; 2013 May; 5(9):3908-15. PubMed ID: 23581883
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multiple core-shell functionalized colloidal mesoporous silica nanoparticles.
    Cauda V; Schlossbauer A; Kecht J; Zürner A; Bein T
    J Am Chem Soc; 2009 Aug; 131(32):11361-70. PubMed ID: 19722649
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nanosized silica modified with carboxylic acid as support for controlled release of herbicides.
    Prado AG; Moura AO; Nunes AR
    J Agric Food Chem; 2011 Aug; 59(16):8847-52. PubMed ID: 21728319
    [TBL] [Abstract][Full Text] [Related]  

  • 57. pH-Tunable calcium phosphate covered mesoporous silica nanocontainers for intracellular controlled release of guest drugs.
    Rim HP; Min KH; Lee HJ; Jeong SY; Lee SC
    Angew Chem Int Ed Engl; 2011 Sep; 50(38):8853-7. PubMed ID: 21826770
    [No Abstract]   [Full Text] [Related]  

  • 58. Toward the design of smart delivery systems controlled by integrated enzyme-based biocomputing ensembles.
    Díez P; Sánchez A; Gamella M; Martínez-Ruíz P; Aznar E; de la Torre C; Murguía JR; Martínez-Máñez R; Villalonga R; Pingarrón JM
    J Am Chem Soc; 2014 Jun; 136(25):9116-23. PubMed ID: 24905667
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stimuli-responsive controlled drug release from a hollow mesoporous silica sphere/polyelectrolyte multilayer core-shell structure.
    Zhu Y; Shi J; Shen W; Dong X; Feng J; Ruan M; Li Y
    Angew Chem Int Ed Engl; 2005 Aug; 44(32):5083-7. PubMed ID: 16015668
    [No Abstract]   [Full Text] [Related]  

  • 60. Gold and silica-coated gold nanoparticles as thermographic labels for DNA detection.
    Cerruti MG; Sauthier M; Leonard D; Liu D; Duscher G; Feldheim DL; Franzen S
    Anal Chem; 2006 May; 78(10):3282-8. PubMed ID: 16689528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.